Skip to main contentSkip to breadcrumbsSkip to sub navSkip to doormat

Anna Obenauf

Metastasis is the final stage of cancer progression and responsible for more than 90% of cancer-related deaths. Effective therapeutic strategies are still lacking and resistance to current therapies pose a formidable challenge. Informed by clinical data and using functional in vivo and in vitro models, our group seeks to understand the mechanistic determinants for metastatic competence and resistance to therapies. Both rely on programs that ensure the cancer cells’ survival during periods of enhanced cellular stress, limited survival cues and attacks by the immune system. Our goal is to enhance the efficacy of current therapies using combinatorial treatment regimens and find new therapeutic avenues to fight metastatic cancer.

Group Members

Jonas Fridolin BAYERL
PhD Student
Shona Mary CRONIN
PhD Student
Anais ELEWAUT
PhD Student
Guillem ESTIVILL I CAPARROS
PhD Student
Johanna FITZ
Senior Research Assistant
Jakob GRÜNEWALD
PhD Student
Martin Gert JÄGER
Postdoc
Pauline Sophie JUNG
PhD Student
Andri KONSTANTINOU
PhD Student
Izabela KRECIOCH
Research Assistant
Anna Christina OBENAUF
Senior Group Leader
Elisabeth POTTENDORFER
PhD Student
Martin SCHÖNLEIN
Postdoc
Kateryna SERBINA
Research Technician
Anton Nikolaus STOIBER
Research Assistant
Milica VULIN
Postdoc
Eva-Maria WIEDEMANN
Senior Research Assistant